Financhill
Sell
16

UPC Quote, Financials, Valuation and Earnings

Last price:
$0.14
Seasonality move :
-6.49%
Day range:
$0.14 - $0.15
52-week range:
$0.14 - $64.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.01x
Volume:
1.3M
Avg. volume:
7.5M
1-year change:
-99.6%
Market cap:
$235.5K
Revenue:
$32.3M
EPS (TTM):
-$76.35

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Universe Pharmaceuticals has -- downside to fair value with a price target of -- per share.

UPC vs. S&P 500

  • Over the past 5 trading days, Universe Pharmaceuticals has underperformed the S&P 500 by -23.32% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Universe Pharmaceuticals does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Universe Pharmaceuticals has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Universe Pharmaceuticals reported revenues of --.

Earnings Growth

  • Universe Pharmaceuticals has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Universe Pharmaceuticals reported earnings per share of --.
Enterprise value:
-4.6M
EV / Invested capital:
--
Price / LTM sales:
0.01x
EV / EBIT:
--
EV / Revenue:
-0.15x
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.62x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$7.6M
Return On Assets:
-32.15%
Net Income Margin (TTM):
-69.41%
Return On Equity:
-49.07%
Return On Invested Capital:
-42.98%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-02-21 2024-02-21 2024-02-21
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Balance Sheet
Current Assets $21.3M $61.8M $51.7M $52.5M $33.5M
Total Assets $26.8M $67.3M $71.4M $70.4M $49.4M
Current Liabilities $9.3M $16.6M $10.2M $23.2M $20.6M
Total Liabilities $9.3M $16.6M $10.2M $23.2M $22.7M
Total Equity $17.5M $50.7M $61.2M $47.1M $26.7M
Total Debt $2.5M $2.7M $4.4M $4.1M $6.5M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-02-21 2024-02-21 2024-02-21
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
UPC
Sector
Market Cap
$235.5K
$44.2M
Price % of 52-Week High
0.23%
48.19%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
-99.6%
-35.43%
Beta (5-Year)
--
0.747
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $0.17
200-day SMA
Sell
Level $21.88
Bollinger Bands (100)
Sell
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $0.31
Relative Strength Index (RSI14)
Sell
Level 25.66
ADX Line
Neutral
Level 0
Williams %R
Buy
Level -96.9677
50-day SMA
Sell
Level $0.60
MACD (12, 26)
Sell
Level -0.17
25-day Aroon Oscillator
Sell
Level -92
On Balance Volume
Neutral
Level --

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.3149)
Buy
CA Score (Annual)
Level (0.6673)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (0.74)
Buy
Piotroski F Score (Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Stock Forecast FAQ

In the current month, UPC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The UPC average analyst price target in the past 3 months is --.

  • Where Will Universe Pharmaceuticals Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Universe Pharmaceuticals share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Universe Pharmaceuticals?

    Analysts are divided on their view about Universe Pharmaceuticals share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Universe Pharmaceuticals is a Sell and believe this share price will rise from its current level to --.

  • What Is Universe Pharmaceuticals's Price Target?

    The price target for Universe Pharmaceuticals over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is UPC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Universe Pharmaceuticals is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of UPC?

    You can purchase shares of Universe Pharmaceuticals via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Universe Pharmaceuticals shares.

  • What Is The Universe Pharmaceuticals Share Price Today?

    Universe Pharmaceuticals was last trading at $0.14 per share. This represents the most recent stock quote for Universe Pharmaceuticals. Yesterday, Universe Pharmaceuticals closed at $0.15 per share.

  • How To Buy Universe Pharmaceuticals Stock Online?

    In order to purchase Universe Pharmaceuticals stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is SoFi Worth?
What Is SoFi Worth?

Since SoFi’s CEO began snapping up shares of the student…

Is CVX a Buy, Sell or Hold?
Is CVX a Buy, Sell or Hold?

Energy giant Chevron Corporation (NYSE:CVX) has long been a pure-play…

What Will NVIDIA Stock Be Worth in 2030?
What Will NVIDIA Stock Be Worth in 2030?

NVIDIA (NASDAQ:NVDA) has been by far one of the best…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
17
CE alert for Feb 21

Celanese [CE] is down 4.21% over the past day.

Sell
22
GLBE alert for Feb 20

Global E Online [GLBE] is down 8.41% over the past day.

Buy
72
HIMS alert for Feb 20

Hims & Hers Health [HIMS] is down 3.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock